Frequency of positive thyroid peroxidase antibody levels in patients of generalized vitiligo

Authors

  • Ambreen Ashraf Allama Iqbal Medical college, Jinnah hospital Lahore

DOI:

https://doi.org/10.66344/jpad.31.4.2021.1758

Abstract

Objective To determine the frequency of positive thyroid peroxidase antibodies in patients of generalized vitiligo.  Methods This cross sectional study was conducted in the Dermatology Unit 1 of Jinnah Hospital, Lahore for a period of six months. 125 cases of generalized vitiligo, of both genders, ages between 15-60 years, and with any duration of disease were enrolled.  Results A total of 125 cases of generalized vitiligo were enrolled. 61.6% (n=77) patients were between 15-30 years of age whereas 38.4 % (n=48) were between 31-60 years of age, Mean was calculated as 31.56±7.77 years, 56.8% (n=71) were male and 43.2% (n=54) were females. Frequency of positive thyroid peroxidase antibodies in patients of generalized vitiligo was recorded in 32.8% (n=41).  Conclusion The frequency of positive thyroid peroxidase antibodies is significant in patients of generalized vitiligo.  

Author Biography

Ambreen Ashraf, Allama Iqbal Medical college, Jinnah hospital Lahore

Consultant dermatologist

Downloads

Published

2022-03-29

How to Cite

1.
Ashraf A. Frequency of positive thyroid peroxidase antibody levels in patients of generalized vitiligo. J Pak Assoc Dermatol [Internet]. 2022Mar.29 [cited 2026May3];31(4):583-7. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1758

Issue

Vol. 31 No. 4 (2021): October - December

Section

Original Articles

License

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.